Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 139

1.

Does rhythm matter in acute heart failure? An insight from the British Society for Heart Failure National Audit.

Anderson SG, Shoaib A, Myint PK, Cleland JG, Hardman SM, McDonagh TA, Dargie H, Keavney B, Garratt CJ, Mamas MA.

Clin Res Cardiol. 2019 Apr 8. doi: 10.1007/s00392-019-01463-5. [Epub ahead of print]

PMID:
30963233
2.

Mechanistic insight into spontaneous transition from cellular alternans to arrhythmia-A simulation study.

Wang W, Zhang S, Ni H, Garratt CJ, Boyett MR, Hancox JC, Zhang H.

PLoS Comput Biol. 2018 Nov 30;14(11):e1006594. doi: 10.1371/journal.pcbi.1006594. eCollection 2018 Nov.

3.

Structural and functional remodeling of the atrioventricular node with aging in rats: The role of hyperpolarization-activated cyclic nucleotide-gated and ryanodine 2 channels.

Saeed Y, Temple IP, Borbas Z, Atkinson A, Yanni J, Maczewski M, Mackiewicz U, Aly M, Logantha SJRJ, Garratt CJ, Dobrzynski H.

Heart Rhythm. 2018 May;15(5):752-760. doi: 10.1016/j.hrthm.2017.12.027. Epub 2017 Dec 27.

4.

The British Cardiovascular Society Annual Conference, Manchester, 5-7 June 2017: the Vice-President's message.

Garratt CJ.

Heart. 2017 Jun;103(11):801-802. doi: 10.1136/heartjnl-2017-311740. No abstract available.

PMID:
28495920
5.

A multinational, drug utilization study to investigate the use of dexmedetomidine (Dexdor®) in clinical practice in the EU.

Weatherall M, Aantaa R, Conti G, Garratt C, Pohjanjousi P, Lewis MA, Moore N, Perez-Gutthann S.

Br J Clin Pharmacol. 2017 Sep;83(9):2066-2076. doi: 10.1111/bcp.13293. Epub 2017 May 10.

6.

Effects of dexmedetomidine and propofol on patient-ventilator interaction in difficult-to-wean, mechanically ventilated patients: a prospective, open-label, randomised, multicentre study.

Conti G, Ranieri VM, Costa R, Garratt C, Wighton A, Spinazzola G, Urbino R, Mascia L, Ferrone G, Pohjanjousi P, Ferreyra G, Antonelli M.

Crit Care. 2016 Jul 2;20(1):206. doi: 10.1186/s13054-016-1386-2.

7.

Aggregation of Marginal Gains in Cardiac Surgery: Feasibility of a Perioperative Care Bundle for Enhanced Recovery in Cardiac Surgical Patients.

Fleming IO, Garratt C, Guha R, Desai J, Chaubey S, Wang Y, Leonard S, Kunst G.

J Cardiothorac Vasc Anesth. 2016 Jun;30(3):665-70. doi: 10.1053/j.jvca.2016.01.017. Epub 2016 Jan 16.

8.

CME Cardiology (100622): self-assessment questionnaire.

Garratt C, Chowdhury TA.

Clin Med (Lond). 2016 Jun;16(3):290-1. doi: 10.7861/clinmedicine.16-3-290. No abstract available.

9.

The BCS Annual Conference, Manchester, 6-8 June 2016. The Vice-President's message.

Garratt C.

Heart. 2016 Jun 1;102(11):809-10. doi: 10.1136/heartjnl-2016-309862. No abstract available.

PMID:
27173370
10.

The British Cardiovascular Society Annual Conference 2015.

Garratt C.

Eur Heart J. 2015 Sep 14;36(35):2344-5. No abstract available.

PMID:
26623467
11.

Effects of Persistent Atrial Fibrillation-Induced Electrical Remodeling on Atrial Electro-Mechanics - Insights from a 3D Model of the Human Atria.

Adeniran I, MacIver DH, Garratt CJ, Ye J, Hancox JC, Zhang H.

PLoS One. 2015 Nov 25;10(11):e0142397. doi: 10.1371/journal.pone.0142397. eCollection 2015.

12.

Effective cascade screening through identification of a mutation in RYR2 in a large family with a history of sudden death.

Bailey C, Blair E, Garratt C, Newman WG.

J Cardiol Cases. 2015 Oct 1;13(1):9-13. doi: 10.1016/j.jccase.2015.08.015. eCollection 2016 Jan.

13.

The BCS Annual Conference, Manchester, 8-10 June 2015. The vice-president's message.

Garratt C.

Heart. 2015 Jun;101(11):826-7. doi: 10.1136/heartjnl-2015-307932. Epub 2015 May 12. No abstract available.

PMID:
25967864
14.

Quality of social experience explains the relation between extraversion and positive affect.

Smillie LD, Wilt J, Kabbani R, Garratt C, Revelle W.

Emotion. 2015 Jun;15(3):339-49. doi: 10.1037/emo0000047. Epub 2015 Jan 19.

PMID:
25603131
15.

Fractionation of electrograms is caused by colocalized conduction block and connexin disorganization in the absence of fibrosis as AF becomes persistent in the goat model.

Kirubakaran S, Chowdhury RA, Hall MC, Patel PM, Garratt CJ, Peters NS.

Heart Rhythm. 2015 Feb;12(2):397-408. doi: 10.1016/j.hrthm.2014.10.027. Epub 2014 Oct 27.

16.

Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure.

Packer M, Colucci W, Fisher L, Massie BM, Teerlink JR, Young J, Padley RJ, Thakkar R, Delgado-Herrera L, Salon J, Garratt C, Huang B, Sarapohja T; REVIVE Heart Failure Study Group.

JACC Heart Fail. 2013 Apr;1(2):103-11. doi: 10.1016/j.jchf.2012.12.004. Epub 2013 Apr 1.

17.

Population pharmacokinetics of dexmedetomidine in critically ill patients.

Välitalo PA, Ahtola-Sätilä T, Wighton A, Sarapohja T, Pohjanjousi P, Garratt C.

Clin Drug Investig. 2013 Aug;33(8):579-87. doi: 10.1007/s40261-013-0101-1.

18.

Pro-arrhythmogenic effects of atrial fibrillation-induced electrical remodelling: insights from the three-dimensional virtual human atria.

Colman MA, Aslanidi OV, Kharche S, Boyett MR, Garratt C, Hancox JC, Zhang H.

J Physiol. 2013 Sep 1;591(17):4249-72. doi: 10.1113/jphysiol.2013.254987. Epub 2013 Jun 3.

19.

Advantages of a subcutaneous implantable cardioverter-defibrillator in LAMP2 hypertrophic cardiomyopathy.

Zaki A, Zaidi A, Newman WG, Garratt CJ.

J Cardiovasc Electrophysiol. 2013 Sep;24(9):1051-3. doi: 10.1111/jce.12142. Epub 2013 Apr 11.

PMID:
23577876
20.

Comparison of Atrial Fibrillation in the Young versus That in the Elderly: A Review.

Sankaranarayanan R, Kirkwood G, Dibb K, Garratt CJ.

Cardiol Res Pract. 2013;2013:976976. doi: 10.1155/2013/976976. Epub 2013 Jan 22.

21.

The Year in Cardiology 2012: arrhythmia and pacing.

Garratt CJ, Saeed Y.

Eur Heart J. 2013 Feb;34(5):333-7. doi: 10.1093/eurheartj/ehs451. Epub 2013 Jan 2. Review.

PMID:
23284092
22.

RCPE UK Consensus Conference on 'Approaching the comprehensive management of atrial fibrillation: evolution or revolution?'.

Stott DJ, Dewar RI, Garratt CJ, Griffith KE, Harding NJ, James MA, Lane DA, Petty DR, Smith PA, Somerville MH, Trueland J; Royal College of Physicians of Edinburgh.

J R Coll Physicians Edinb. 2012;42 Suppl 18:3-4. doi: 10.4997/JRCPE.2012.S01. No abstract available.

PMID:
22518389
23.

The clinical management of relatives of young sudden unexplained death victims; implantable defibrillators are rarely indicated.

Caldwell J, Moreton N, Khan N, Kerzin-Storrar L, Metcalfe K, Newman W, Garratt CJ.

Heart. 2012 Apr;98(8):631-6. doi: 10.1136/heartjnl-2011-300924.

PMID:
22505462
24.

RCPE UK Consensus Conference on 'approaching the comprehensive management of atrial fibrillation: evolution or revolution?'.

Stott DJ, Dewar RI, Garratt CJ, Griffith KE, Harding NJ, James MA, Lane DA, Petty DR, Smith PA, Somerville MH, Trueland J.

J R Coll Physicians Edinb. 2012 Mar;42(1):34-5. doi: 10.4997/JRCPE.2012.S01. No abstract available.

PMID:
22441062
25.

Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials.

Jakob SM, Ruokonen E, Grounds RM, Sarapohja T, Garratt C, Pocock SJ, Bratty JR, Takala J; Dexmedetomidine for Long-Term Sedation Investigators.

JAMA. 2012 Mar 21;307(11):1151-60. doi: 10.1001/jama.2012.304.

PMID:
22436955
26.

Pharmacokinetics of prolonged infusion of high-dose dexmedetomidine in critically ill patients.

Iirola T, Aantaa R, Laitio R, Kentala E, Lahtinen M, Wighton A, Garratt C, Ahtola-Sätilä T, Olkkola KT.

Crit Care. 2011;15(5):R257. doi: 10.1186/cc10518. Epub 2011 Oct 26.

27.

Virtual tissue engineering of the human atrium: modelling pharmacological actions on atrial arrhythmogenesis.

Aslanidi OV, Al-Owais M, Benson AP, Colman M, Garratt CJ, Gilbert SH, Greenwood JP, Holden AV, Kharche S, Kinnell E, Pervolaraki E, Plein S, Stott J, Zhang H.

Eur J Pharm Sci. 2012 Jul 16;46(4):209-21. doi: 10.1016/j.ejps.2011.08.014. Epub 2011 Aug 24.

PMID:
21888968
28.

Ventricular fibrillation following successful DC cardioversion for atrial fibrillation.

Caldwell JC, Woolfson P, Clarke B, Garratt CJ.

Pacing Clin Electrophysiol. 2012 Dec;35(12):e361-4. doi: 10.1111/j.1540-8159.2010.03020.x. Epub 2011 Jan 20.

PMID:
21251025
29.

Mycobacterium tuberculosis causing infection of an implantable biventricular defibrillator.

Luckie M, Zaidi A, Woodhead M, Garratt C.

Indian J Tuberc. 2010 Oct;57(4):213-5.

PMID:
21141340
30.

Heart Rhythm UK position statement on clinical indications for implantable cardioverter defibrillators in adult patients with familial sudden cardiac death syndromes.

Garratt CJ, Elliott P, Behr E, Camm AJ, Cowan C, Cruickshank S, Grace A, Griffith MJ, Jolly A, Lambiase P, McKeown P, O'Callagan P, Stuart G, Watkins H; Heart Rhythm UK Familial Sudden Cardiac Death Syndromes Statement Development Group.

Europace. 2010 Aug;12(8):1156-75. doi: 10.1093/europace/euq261.

PMID:
20663787
31.

Effects of angiotensin receptor blockade on atrial electrical remodelling and the 'second factor' in a goat burst-paced model of atrial fibrillation.

Hall MC, Kirubakaran S, Choudhury R, Abidin N, Peters NS, Garratt CJ.

J Renin Angiotensin Aldosterone Syst. 2010 Dec;11(4):222-33. doi: 10.1177/1470320310369604. Epub 2010 May 27.

PMID:
20507873
32.

What are the thromboembolic risks of heart failure combined with chronic or paroxysmal AF?

Caldwell JC, Mamas MA, Neyses L, Garratt CJ.

J Card Fail. 2010 Apr;16(4):340-7. doi: 10.1016/j.cardfail.2009.12.004. Epub 2010 Feb 4. Review.

PMID:
20350702
33.

Right coronary artery damage during cavotricuspid isthmus ablation.

Caldwell JC, Fath-Odoubadi F, Garratt CJ.

Pacing Clin Electrophysiol. 2010 Dec;33(12):e110-3. doi: 10.1111/j.1540-8159.2010.02731.x. Review.

PMID:
20345628
34.

A new approach to confirming or excluding ventricular pre-excitation on a 12-lead ECG.

Eisenberger M, Davidson NC, Todd DM, Garratt CJ, Fitzpatrick AP.

Europace. 2010 Jan;12(1):119-23. doi: 10.1093/europace/eup345.

PMID:
19903669
35.

Atrial fibrillation is under-recognized in chronic heart failure: insights from a heart failure cohort treated with cardiac resynchronization therapy.

Caldwell JC, Contractor H, Petkar S, Ali R, Clarke B, Garratt CJ, Neyses L, Mamas MA.

Europace. 2009 Oct;11(10):1295-300. doi: 10.1093/europace/eup201. Epub 2009 Aug 1.

PMID:
19648586
36.

A meta-analysis of the prognostic significance of atrial fibrillation in chronic heart failure.

Mamas MA, Caldwell JC, Chacko S, Garratt CJ, Fath-Ordoubadi F, Neyses L.

Eur J Heart Fail. 2009 Jul;11(7):676-83. doi: 10.1093/eurjhf/hfp085.

37.

Atrial proarrhythmia due to increased inward rectifier current (I(K1)) arising from KCNJ2 mutation--a simulation study.

Kharche S, Garratt CJ, Boyett MR, Inada S, Holden AV, Hancox JC, Zhang H.

Prog Biophys Mol Biol. 2008 Oct-Nov;98(2-3):186-97. doi: 10.1016/j.pbiomolbio.2008.10.010. Epub 2008 Nov 9.

PMID:
19041665
38.

How common is asymptomatic paroxysmal atrial fibrillation in chronic heart failure?

Caldwell J, Mamas M, Garratt C, Neyses L.

Scand Cardiovasc J. 2008 Dec;42(6):366; author reply 367. doi: 10.1080/14017430802492372. No abstract available.

PMID:
18932093
39.

Disappearing hot spot on an indium 111 white cell scan: a case report.

Petkar S, Hamid T, Pendegrast B, Garratt C, Arumugam P.

J Nucl Cardiol. 2008 Jan-Feb;15(1):e1-5. doi: 10.1016/j.nuclcard.2007.11.012. No abstract available.

PMID:
18242469
40.

Safety and acceptability of implantation of internal cardioverter-defibrillators under local anesthetic and conscious sedation.

Fox DJ, Davidson NC, Royle M, Bennett DH, Clarke B, Garratt CJ, Hall MC, Zaidi AM, Patterson K, Fitzpatrick AP.

Pacing Clin Electrophysiol. 2007 Aug;30(8):992-7. Erratum in: Pacing Clin Electrophysiol. 2007 Nov;30(11):1423. Royle, Martin [added].

PMID:
17669082
41.

Role of up-regulation of IK1 in action potential shortening associated with atrial fibrillation in humans.

Zhang H, Garratt CJ, Zhu J, Holden AV.

Cardiovasc Res. 2005 Jun 1;66(3):493-502. Epub 2005 Feb 24.

PMID:
15914114
42.
43.

The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death.

Lau EW, Griffith MJ, Pathmanathan RK, Ng GA, Clune MM, Cooper J, Marshall HJ, Forsey PR, Stafford PJ, Gray RG, Skehan JD, Garratt CJ.

Europace. 2004 Jul;6(4):257-66.

PMID:
15172648
44.
45.

Holter monitoring vs tilt testing in the investigation of suspected vasovagal syncope.

Fitchet A, Stirling M, Burnett G, Goode GK, Garratt CJ, Fitzpatrick AP.

Pacing Clin Electrophysiol. 2003 Jul;26(7 Pt 1):1523-7.

PMID:
12914632
46.

Effect of amiodarone on dispersion of atrial refractoriness and cycle length in patients with atrial fibrillation.

Fynn SP, Todd DM, Hobbs WJ, Armstrong KL, Fitzpatrick AP, Garratt CJ.

J Cardiovasc Electrophysiol. 2003 May;14(5):485-91.

PMID:
12776865
47.

Comprehensive cardiac rehabilitation programme for implantable cardioverter-defibrillator patients: a randomised controlled trial.

Fitchet A, Doherty PJ, Bundy C, Bell W, Fitzpatrick AP, Garratt CJ.

Heart. 2003 Feb;89(2):155-60.

48.

The effectiveness of serial cardioversion therapy for recurrence of atrial fibrillation.

Fynn SP, Garratt CJ.

Eur Heart J. 2002 Oct;23(19):1487-9. No abstract available.

PMID:
12242067
49.

Clinical evaluation of a policy of early repeated internal cardioversion for recurrence of atrial fibrillation.

Fynn SP, Todd DM, Hobbs WJ, Armstrong KL, Fitzpatrick AP, Garratt CJ.

J Cardiovasc Electrophysiol. 2002 Feb;13(2):135-41.

PMID:
11902145
50.

Flecainide widens the excitable gap at pivot points of premature turning wavefronts in rabbit ventricular myocardium.

Danse PW, Garratt CJ, Allessie MA.

J Cardiovasc Electrophysiol. 2001 Sep;12(9):1010-7.

PMID:
11573690

Supplemental Content

Loading ...
Support Center